Contrast-medium-induced nephrotoxicity: are all answers in for acetylcysteine?
Thomsen
H S
HS
D000111:Acetylcysteine / Q000008:administration & dosage*; D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000517:prevention & control; D003131:Combined Modality Therapy; D003287:Contrast Media / Q000009:adverse effects*; D004311:Double-Blind Method; D005440:Fluid Therapy; D006801:Humans; D007472:Iohexol / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D011292:Premedication; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D003287:Contrast Media; D007472:Iohexol; C038192:iopromide; D000111:Acetylcysteine